Amicus Therapeutics Securities Litigation

In re: Amicus Therapeutics, Inc. Securities Litigation, No. 3:15-cv-07350 (D. N.J.)

Update

On April 14, 2017, Block & Leviton LLP filed for preliminary approval of a $3.75 million settlement in this case. That motion is currently pending before the Court. Check back for additional updates.

Case Documents